New SPIRIVA Respimat Inhaler Completes European Approval Process for COPD

Boehringer Ingelheim and Pfizer announced successful completion of the approval process for authorisation to market SPIRIVA Respimat in the European Union for people with chronic obstructive pulmonary disease (COPD).
FinanzNachrichten